$OCGN If those scientists who sit on the FDA panel reviewing OCGN's vaccine for approval want to get jobs at PFE , JNJ or other big pharma's when they leave the FDA, they better not approve Covaxin, or at least drag out the approval process as long as they can. The FDA scientists and the pharma industry is one big revolving door, unfortunately
1
1
1 Like